<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7335243\results\search\testTrace\results.xml">
  <result pre="have proven effective in randomized clinical trials, currently, the rapid" exact="detection" post="technology along with several promising therapeutics for COVID-19 have"/>
  <result pre="and the disease surveillance system, the lack of efficacious drug" exact="treatment" post="and correlated high morbidity cases of the SARS-CoV-2 along"/>
  <result pre="will first briefly describe the status of epidemiology, mechanism and" exact="diagnosis" post="of COVID-19. In addition to the discussion of current"/>
  <result pre="strategies for COVID-19, the emphasis has been given to the" exact="treatment" post="options and drug discovery of COVID-19. We will refer"/>
  <result pre="drug discovery of COVID-19. We will refer to the drug" exact="screening" post="progress and the development of vaccines for the COVID-19"/>
  <result pre="demonstrated to shed the infectious virus, serving as a potential" exact="infection" post="source to drive the transmission of the COVID-19 [17]."/>
  <result pre="rehabilitees continuously showed a positive RT-PCR result, implicating that asymptomatic" exact="infection" post="during incubation or recovery from COVID-19 may pose a"/>
  <result pre="for quarantine), the longer incubation time indicates the adjustment of" exact="screening" post="and control policies [22]. The early outbreak data of"/>
  <result pre="need to further implementing the timely diagnosis, along with efficient" exact="isolation" post="of patients, to cut down the R0 of SARS-CoV-2"/>
  <result pre="pandemic control. 4 Diagnosis and pathogenesis of SARS-CoV-2 4.1 Diagnostic" exact="testing" post="for COVID-19 Rapid and accurate diagnosis of COVID-19 is"/>
  <result pre="of SARS-CoV-2 4.1 Diagnostic testing for COVID-19 Rapid and accurate" exact="diagnosis" post="of COVID-19 is of considerable significance for controlling outbreaks"/>
  <result pre="outbreaks in the communities and hospitals [38]. Technologies such as" exact="polymerase chain reaction" post="(PCR), reverse-transcription polymerase chain reaction (RT-PCR), real-time RT-PCR (rRT-PCR),"/>
  <result pre="hospitals [38]. Technologies such as polymerase chain reaction (PCR), reverse-transcription" exact="polymerase chain reaction" post="(RT-PCR), real-time RT-PCR (rRT-PCR), and reverse transcription loop-mediated isothermal"/>
  <result pre="swab tests have ripened into the standard evaluation for the" exact="diagnosis" post="of COVID-19 infection. So far, three new RT-PCR tests"/>
  <result pre="spike genes of SARS-CoV-2 had been inaugurated, with extremely lower" exact="detection" post="limit in vitro[42]. The SARS-CoV E gene detection was"/>
  <result pre="extremely lower detection limit in vitro[42]. The SARS-CoV E gene" exact="detection" post="was superior to the RdRp gene test combined with"/>
  <result pre="terms of getting tested and receiving a diagnosis. As gene" exact="detection" post="of SARS-CoV-2 might provide false negative results, it can"/>
  <result pre="fatigue, sore throat, cough or dyspnea due to exposure, the" exact="diagnosis" post="of COVID-19 infection should be conducted with typical chest"/>
  <result pre="cough or dyspnea due to exposure, the diagnosis of COVID-19" exact="infection" post="should be conducted with typical chest computerized tomography (CT)"/>
  <result pre="(specific high-sensitivity enzymatic reporter unlocking) platform can be harnessed for" exact="diagnosis" post="of SARS-CoV-2 [47]. In this system, RNA-targeting Cas13 enzyme"/>
  <result pre="Overall, combined with immunochromatography, colloidal gold, and other biotechnologies, associative" exact="detection" post="strategies have been progressed swiftly. 4.2 Pathogenesis of SARS-CoV-2"/>
  <result pre="block the entrance and may give rise to an underlying" exact="treatment" post="option. Notably, the ability that S can readily obtain"/>
  <result pre="the acute respiratory distress syndrome, exuberant inflammatory responses during the" exact="infection" post="process were also observed in clinical, giving rise to"/>
  <result pre="to the host, lay the foundation for developing specific targeted" exact="treatment" post="and prevention. A general idea of pivotal targets for"/>
  <result pre="directly targeting the highly conserved S2 subunit may be potential" exact="treatment" post="candidates. Fig. 6 Crucial SARS-CoV-2 targets for novel antiviral"/>
  <result pre="al. recently identified the host cell pathways modulated by SARS-CoV-2" exact="infection" post="and revealed that suppression of these pathways may prevent"/>
  <result pre="prevent viral replication in human cells [65]. Of note, SARS-CoV-2" exact="infection" post="profile was determined by translatome3 and proteome proteomics at"/>
  <result pre="them clinically valuable. 5.2 Drug discovery approaches toward anti-SARS-CoV-2 drug" exact="screening" post="The drug discovery strategy bears the brunt of the"/>
  <result pre="a method holds the potential of offering a prompt, high-throughput" exact="screening" post="of many off-the-shelf composites, which can thereby be further"/>
  <result pre="off-the-shelf composites, which can thereby be further assessed via antiviral" exact="detection" post="test. Importantly, a variety of different types of agents"/>
  <result pre="COVID-19 (ChiCTR2000029387) Favipiravir (T-705) [78] A guanine analog for the" exact="treatment" post="of influenza virus infections Toyama Under clinical trial for"/>
  <result pre="COVID-19 (NCT04252664) Type I interferons IFN-Î²1 [80] Used as a" exact="treatment" post="for multiple sclerosis Multiple companies Treatment of COVID-19 in"/>
  <result pre="(ChiCTR2000029539) Chloroquine Chloroquine and hydroxychloroquine [81] Oral prescription drugs for" exact="treatment" post="of malaria and certain inflammatory conditions Multiple companies Under"/>
  <result pre="in clinical trials for pre-exposure or post-exposure prophylaxis of SARS-CoV-2" exact="infection" post="Antibodies CR3022 [82] A SARS Cov-specific human monoclonal antibody"/>
  <result pre="[90]. In the United States, the first case of SARS-CoV-2" exact="infection" post="was reported, and remdesivir was administered. The patient's clinical"/>
  <result pre="patient's clinical condition improved after only one day of remdesivir" exact="treatment" post="[79]. A newly released research offered remdesivir for COVID-19"/>
  <result pre="basis of sympathy. In the cohort of patients admitted for" exact="treatment" post="of severe COVID-19, patients treated with sympathetic remdesivir achieved"/>
  <result pre="had recovered from their illness within two weeks of receiving" exact="treatment" post="[93]. However, this study lacked a placebo-controlled arm. Moreover,"/>
  <result pre="reactions aroused by lopinavir-ritonavir, it is worth noting that lopinavir-ritonavir" exact="treatment" post="alone may fail to offer benefits in comparison with"/>
  <result pre="number of deaths were observed among the patients with lopinavir-ritonavir" exact="treatment" post="in the late stage of this disease in contrast"/>
  <result pre="that it is an ideal candidate antiviral drug against SARS-CoV-2" exact="infection" post="in Vero E6 cells with EC50 value of around"/>
  <result pre="relate with the determination of whether the benefit of chloroquine" exact="treatment" post="is hinged on the age of the patients as"/>
  <result pre="might be an increased frequency of ventricular arrhythmias during the" exact="treatment" post="of COVID-19 diseases [108]. The WHO has also suspended"/>
  <result pre="of COVID-19 diseases [108]. The WHO has also suspended hydroxychloroquine" exact="treatment" post="in COVID-19 solidarity trial in terms of the outcomes"/>
  <result pre="neutralization activity in vitro against SARS-CoV-2. Moreover, CB6â€…could suppress SARS-CoV-2" exact="infection" post="in rhesus monkeys at both prophylactic and treatmentâ€…settings. The"/>
  <result pre="and direct interface-residue competition [111]. Another recent study revealed the" exact="isolation" post="and characterization of 206 RBD-specific mAbs derived from single"/>
  <result pre="proof of delayed viral clearance and increased rates of secondary" exact="infection" post="and mortality [114]. In a study of 41 COVID-19"/>
  <result pre="current WHO interim guidance, glucocorticoids are not recommended for routine" exact="treatment" post="unless otherwise indicated, as other coronaviruses and influenza studies"/>
  <result pre="as psychosis, diabetes, and avascular necrosis [116]. In general, the" exact="treatment" post="with corticosteroids may be harmful, but such agents can"/>
  <result pre="Abs in the plasma of patients recovering from the viral" exact="infection" post="may inhibit viremia. To date, in the previous SARS"/>
  <result pre="early after the onset of symptoms reduced overall mortality after" exact="treatment" post="compared to placebo or no treatment [118]. For the"/>
  <result pre="reduced overall mortality after treatment compared to placebo or no" exact="treatment" post="[118]. For the test of convalescent plasma effect on"/>
  <result pre="decline in viral loads [119]. During the emerging of COVID-19" exact="infection" post="in China, the National Health Commission of China also"/>
  <result pre="Medicine was also regarded as an alternative method for the" exact="treatment" post="of COVID-19 disease in high-risk populations. During the COVID-19"/>
  <result pre="Flos and Fructus forsythia were commonly harnessed for improving the" exact="treatment" post="effect of COVID-19 infections. Herbal medications can offer a"/>
  <result pre="infections. Herbal medications can offer a more effective and personalized" exact="treatment" post="by adjusting the specific medicine for each patient based"/>
  <result pre="[120]. Previous studies also indicated that the patients with SARS-CoV" exact="infection" post="have benefited from TCM treatment [121], involving amelioration of"/>
  <result pre="that the patients with SARS-CoV infection have benefited from TCM" exact="treatment" post="[121], involving amelioration of adverse effects of tranditional therapeutics."/>
  <result pre="the clinical application of traditional Chinese medicine in the COVID-19" exact="treatment" post="[123]. Hence, rigorous clinical trials on large populations should"/>
  <result pre="pneumonia, especially for critically ill patients [124]. As mentioned, COVID-19" exact="infection" post="may induce uncontrolled inflammatory innate reactions along with undermined"/>
  <result pre="immune reactions, subsequently leading to detrimental tissue damage. MSC-based immunomodulation" exact="treatment" post="is able to counteract the cytokine storm aroused by"/>
  <result pre="and very dismal prognosis [127]. Although such a kind of" exact="treatment" post="is an ideal option for COVID-19 therapy, it has"/>
  <result pre="use of mixed inhalation of hydrogen and oxygen (H2/O2: 66.6%/33.3%)" exact="treatment" post="may improve the symptoms [131]. Lung transplantation can be"/>
  <result pre="in a clinical study, lung transplantation may offer the ultimate" exact="treatment" post="option for severe patients to avoid certain deaths, while"/>
  <result pre="terms of controlling the epidemic aroused by emerging viruses, rapid" exact="diagnosis" post="and effective vaccines serve as a complementation to antiviral"/>
  <result pre="BNT162 mRNA vaccine expressing codon-optimized undisclosed SARS-CoV-2 proteins BioNTech Clinical" exact="testing" post="to begin late April STARR Self-transcribing and replicating RNA"/>
  <result pre="on S protein and selected epitopes LineaRx Four candidates for" exact="testing" post="by the beginning of May or June / Undisclosed"/>
  <result pre="Undisclosed recombinant SARS-CoV-2 protein VLP produced in tobacco Medicago preclinical" exact="testing" post="ongoing with clinical trials to begin summer 2020 /"/>
  <result pre="during the vaccine development researches [157]. Clover Biopharmaceuticals was pre-clinically" exact="testing" post="a recombinant subunit vaccine in the light of the"/>
  <result pre="cell accumulation, and plasmacytoid dendritic cell growth after Fc-fused IL-7" exact="treatment" post="in the virus infection models [166]. 7 Conclusions and"/>
  <result pre="dendritic cell growth after Fc-fused IL-7 treatment in the virus" exact="infection" post="models [166]. 7 Conclusions and inspirations Despite prodigious global"/>
  <result pre="is not very high, implicating the requirement of more swab" exact="testing" post="are need to confirm the diagnosis. With the continuous"/>
  <result pre="novel therapeutics that target viral replication or immunopathology, currently, rapid" exact="screening" post="of therapeutic agents to repurpose FDA-approved and well-characterized agents"/>
  <result pre="therapeutic optionsNat Rev Drug Discov15201632726868298 5XiaS.LiuM.WangC.XuW.LanQ.FengS.Inhibition of SARS-CoV-2 (previously 2019-nCoV)" exact="infection" post="by a highly potent pan-coronavirus fusion inhibitor targeting its"/>
  <result pre="novel coronavirus disease 2019 (COVID-19)J Microbiol Biotechnol30202031332238757 17HoehlS.RabenauH.BergerA.KortenbuschM.CinatlJ.BojkovaD.Evidence of SARS-CoV-2" exact="infection" post="in returning travelers from Wuhan, ChinaN Engl J Med38220201278128032069388"/>
  <result pre="37ForsterP.ForsterL.RenfrewC.ForsterM.Phylogenetic network analysis of SARS-CoV-2 genomesProc Natl Acad Sci117172020202004999 38ToK.K.W.TsangO.T.Y.YipC.C.Y.ChanK.H.WuT.C.ChanJ.M.Consistent" exact="detection" post="of 2019 novel coronavirus in salivaClin Infect Dis2020ciaa149 39ChanJ.F.W.ChoiG.K.Y.TsangA.K.L.TeeK.M.LamH.Y.YipC.C.Y.Development"/>
  <result pre="coronavirusesJ Clin Microbiol5320152722272626019210 40BhadraS.JiangY.S.KumarM.R.JohnsonR.F.HensleyL.E.EllingtonA.D.Real-time sequence-validated loop-mediated isothermal amplification assays for" exact="detection" post="of Middle East respiratory syndrome coronavirus (MERS-CoV)PLoS One42015e0123126 41SheridanC.Fast,"/>
  <result pre="tests come online to curb coronavirus pandemicNat Biotechnol38202051551832203294 42ChanJ.F.W.YipC.C.Y.ToK.K.W.TangT.H.C.WongS.C.Y.LeungK.H.Improved molecular" exact="diagnosis" post="of COVID-19 by the novel, highly sensitive and specific"/>
  <result pre="Singh J, Chiu CY, Chen JS. A protocol for rapid" exact="detection" post="of the 2019 novel coronavirus SARS-CoV-2 using CRISPR diagnostics:"/>
  <result pre="coronavirus SARS-CoV-2 using CRISPR diagnostics: SARS-CoV-22020. https://mammoth.bio/wp-content/uploads/2020/04/200423-A-protocol-for-rapid-detection-of-SARS-CoV-2-using-CRISPR-diagnostics_3.pdf. 48XiaoF.TangM.ZhengX.LiC.HeJ.HongZ.Evidence for gastrointestinal" exact="infection" post="of SARS-CoV-2Gastroenterology15820201831183332142773 49HuangC.WangY.LiX.RenL.ZhaoJ.HuY.Clinical features of patients infected with 2019"/>
  <result pre="SARS with human interferonsLancet362200329329412892961 70DyallJ.ColemanC.M.HartB.J.VenkataramanT.HolbrookM.R.KindrachukJ.Repurposing of clinically developed drugs for" exact="treatment" post="of Middle East respiratory syndrome coronavirus infectionAntimicrob Agents Chemother5820144885489324841273"/>
  <result pre="and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus" exact="infection" post="as identified by temporal kinome analysisAntimicrob Agents Chemother5920151088109925487801 72ElshabrawyH.A.FanJ.HaddadC.S.RatiaK.BroderC.C.CaffreyM.Identification"/>
  <result pre="Ebola, Hendra, and Nipah viruses by using a novel high-throughput" exact="screening" post="assayJ Virol8820144353436524501399 73de WildeA.H.JochmansD.PosthumaC.C.Zevenhoven-DobbeJ.C.van NieuwkoopS.BestebroerT.M.Screening of an FDA-approved compound"/>
  <result pre="cohort studyHong Kong Med J9200339940614660806 75ChuC.M.ChengV.C.C.HungI.F.N.WongM.M.L.ChanK.H.ChanK.S.Role of lopinavir/ritonavir in the" exact="treatment" post="of SARS: initial virological and clinical findingsThorax59200425225614985565 76YamamotoN.YangR.YoshinakaY.AmariS.NakanoT.CinatlJ.HIV protease"/>
  <result pre="studyInt J Infect Dis202014424624406736 78De ClercqE.New Nucleoside analogues for the" exact="treatment" post="of hemorrhagic fever virus infectionsChem Asian J1420193962396831389664 79HolshueM.L.De BoltC.LindquistS.LofyK.H.WiesmanJ.BruceH.First"/>
  <result pre="StatesN Engl J Med382202092993632004427 80SallardE.LescureF.X.YazdanpanahY.MentreF.Peiffer-SmadjaN.Type 1 interferons as a potential" exact="treatment" post="against COVID-19Antiviral Res1782020104791 81CDC. Information for clinicians on therapeutic"/>
  <result pre="synergistic with alpha interferonAntimicrob Agents Chemother58201426727324145541 85SoL.K.Y.LauA.C.W.YamL.Y.C.CheungT.M.T.PoonE.YungR.W.H.Development of a standard" exact="treatment" post="protocol for severe acute respiratory syndromeLancet36120031615161712747883 86WenzelR.P.EdmondM.B.Managing SARS amidst"/>
  <result pre="Infect Dis62006676916439323 101VincentM.J.BergeronE.BenjannetS.EricksonB.R.RollinP.E.KsiazekT.G.Chloroquine is a potent inhibitor of SARS coronavirus" exact="infection" post="and spreadVirol J220056916115318 102GaoJ.TianZ.YangX.Breakthrough: chloroquine phosphate has shown apparent"/>
  <result pre="spreadVirol J220056916115318 102GaoJ.TianZ.YangX.Breakthrough: chloroquine phosphate has shown apparent efficacy in" exact="treatment" post="of COVID-19 associated pneumonia in clinical studiesBiosci Trends4120207273 103JallouliM.GalicierL.ZahrN.AumaitreO.FrancesC.Le"/>
  <result pre="and projection of optimized dosing design of hydroxychloroquine for the" exact="treatment" post="of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Clin Infect"/>
  <result pre="Res2020104762 108MehraM.R.DesaiS.S.RuschitzkaF.PatelA.N.Hydroxychloroquine or chloroquine with or without a macrolide for" exact="treatment" post="of COVID-19: a multinational registry analysisLancet202010.1016/S0140-6736(20)31180-6 109Kunzmann K.A.WHO suspends"/>
  <result pre="of COVID-19: a multinational registry analysisLancet202010.1016/S0140-6736(20)31180-6 109Kunzmann K.A.WHO suspends hydroxychloroquine" exact="treatment" post="in COVID-19 solidarity trial2020. https://www.contagionlive.com/news/who-hydroxychloroquine-treatment-covid-19-solidarity-trial. 110JeanS.S.LeeP.I.HsuehP.R.Treatment options for COVID-19:"/>
  <result pre="for therapyNat Rev Immunol20202026927032273594 114RussellC.D.MillarJ.E.BaillieJ.K.Clinical evidence does not support corticosteroid" exact="treatment" post="for 2019-nCoV lung injuryLancet395202047347532043983 115ZhouM.ZhangX.QuJ.Coronavirus disease 2019 (COVID-19): a"/>
  <result pre="2019 (COVID-19): a clinical updateFront Med142202012613532240462 116LeeN.ChanK.C.A.HuiD.S.NgE.K.O.WuA.ChiuR.W.K.Effects of early corticosteroid" exact="treatment" post="on plasma SARS-associated Coronavirus RNA concentrations in adult patientsJ"/>
  <result pre="118Mair-JenkinsJ.Saavedra-CamposM.BaillieJ.K.ClearyP.KhawF.-.M.LimW.S.The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the" exact="treatment" post="of severe acute respiratory infections of viral etiology: a"/>
  <result pre="with COVID-19 with convalescent plasmaJAMA32316202015821589 120DuH.Z.HouX.Y.MiaoY.H.HuangB.S.LiuD.H.Traditional chinese medicine: an effective" exact="treatment" post="for 2019 novel coronavirus pneumonia (NCP)Chin J Nat Med18202020621032245590"/>
  <result pre="against novel coronavirus (SARS-CoV-2)Pharmacol Res1562020104761 123YangY.IslamM.S.WangJ.LiY.ChenX.Traditional chinese medicine in the" exact="treatment" post="of patients infected with 2019-new coronavirus (SARS-CoV-2): a review"/>
  <result pre="Cell Rev Rep163202042743332281052 126Williams R.Are mesenchymal stem cells a promising" exact="treatment" post="for COVID-19?2020. https://www.the-scientist.com/news-opinion/are-mesenchymal-stem-cells-a-promising-treatment-for-covid-19â€&quot;67402. 127Stem cell therapy: a promising treatment"/>
  <result pre="promising treatment for COVID-19?2020. https://www.the-scientist.com/news-opinion/are-mesenchymal-stem-cells-a-promising-treatment-for-covid-19â€&quot;67402. 127Stem cell therapy: a promising" exact="treatment" post="for COVID-19?. https://www.technologynetworks.com/biopharma/product-news/stem-cell-therapy-a-promising-treatment-for-covid-19-333498. 128Malicdem D.Hydrogen peroxide as treatment for"/>
  <result pre="a promising treatment for COVID-19?. https://www.technologynetworks.com/biopharma/product-news/stem-cell-therapy-a-promising-treatment-for-covid-19-333498. 128Malicdem D.Hydrogen peroxide as" exact="treatment" post="for coronavirus infection: does it work?https://www.medicaldaily.com/hydrogen-peroxide-treatment-coronavirus-infection-does-work-451710. 129KampfG.TodtD.PfaenderS.SteinmannE.Persistence of coronaviruses"/>
  <result pre="healingJ Transl Sci6202016 131Hydrogen molecular biomedicine promotes new coronary pneumonia" exact="diagnosis" post="and treatment plan. https://www.sohu.com/a/375239106_99929695 132ChenJ.Y.QiaoK.LiuF.WuB.XuX.JiaoG.Q.Lung transplantation as therapeutic option"/>
  <result pre="Sci6202016 131Hydrogen molecular biomedicine promotes new coronary pneumonia diagnosis and" exact="treatment" post="plan. https://www.sohu.com/a/375239106_99929695 132ChenJ.Y.QiaoK.LiuF.WuB.XuX.JiaoG.Q.Lung transplantation as therapeutic option in acute"/>
  <result pre="https://pipelinereview.com/index.php/2020040674247/Vaccines/INOVIO-Initiates-Phase-1-Clinical-Trial-Of-Its-COVID-19-Vaccine-and-Plans-First-Dose-Today.html. 151YuJ.Y.TostanoskiL.H.PeterL.MercadoN.B.McMahanK.MahrokhianS.H.DNA vaccine protection against SARS-CoV-2 in rhesus macaquesScience2020eabc6284 152ChandrashekarA.LiuJ.MartinotA.J.McMahanK.MercadoN.B.PeterL.SARS-CoV-2" exact="infection" post="protects against rechallenge in rhesus macaquesScience2020eabc4776 153Inovio's DNA-encoded monoclonal"/>
  <result pre="dendritic cells contribute to the protective immunity induced by intranasal" exact="treatment" post="with Fc-fused interleukin-7 against lethal influenza virus infectionImmune Netw17201734335129093655"/>
 </snippets>
</snippetsTree>
